Skip to NavigationSkip to content

Pharmafile - Sales and Marketing

Roche's Tecentriq/Avastin combo smashes endpoints at Phase 3 in unresectable hepatocellular carcinoma
New Phase 3 data has emerged demonstrating the efficacy of Roche’s Tecentriq  in combination with Avastin in the treatment of unresectable...
AstraZeneca receives FDA approval for Farxiga
AstraZeneca have announced that the US FDA has approved Farxiga (dapagliflozin) to reduce the risk of hospitalisation for heart failure in adults...
GlaxoSmithKline sells two vaccines for up to £822m
GlaxoSmithKline has announced it will divest two of its major vaccines to Denmark-based Bavarian Nordic in a deal that will see the company receive...
Top Ten most popular articles on Pharmafile.com this week
It’s time for a rundown of the top 10 articles on PharmaFile this past week. The past seven days saw the first and only transdermal patch for...
>> More Sales and Marketing News Stories

Features

Medical cannabis: Growth by leaps and bounds

In June 2019, Pharmafocus visited the headquarters of cannabis company Canopy Growth in the Canadian town of Smiths Falls. Louis Goss...

>> More Features

Appointments

Gilead appoints Andrew Dickinson as CFO

Gilead Sciences have announced that Andrew Dickinson has been appointed as Chief Financial Officer (CFO) effective 1 November.

Dickinson...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches